Status:
UNKNOWN
Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates
Lead Sponsor:
University of Ulm
Conditions:
Arterial Hypotension
Eligibility:
All Genders
Up to 44 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to examine the effects of Dobutamine as compared to Dopamine in term and preterm neonates with arterial hypotension on cerebral and renal oxygenation, fractional tissue ox...
Eligibility Criteria
Inclusion
- fluid refractory arterial hypotension
- newborn infant below 44 weeks postmenstrual age
- parental informed consent
Exclusion
- preterm infant below 28 weeks postmenstrual age during the first week of life
- congenital life-threatening malformations
- decision for palliative care
- hemorrhagic shock
- other obvious cause for arterial hypotension that requires immediate specific treatment, e.g. tension pneumothorax
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01427686
Start Date
June 1 2011
End Date
December 1 2016
Last Update
April 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center, Ulm University
Ulm, Baden-Wurttemberg, Germany, 89075